Is Biological Subtype Prognostic of Locoregional Recurrence Risk in Women With pT1-2N0 Breast Cancer Treated With Mastectomy?

Author(s):  
Pauline T. Truong ◽  
Betro T. Sadek ◽  
Maria F. Lesperance ◽  
Cheryl S. Alexander ◽  
Mina Shenouda ◽  
...  
2012 ◽  
Vol 23 (3) ◽  
pp. 802-803 ◽  
Author(s):  
G. Semprini ◽  
F. Cattin ◽  
L. Lazzaro ◽  
C. Cedolini ◽  
P.C. Parodi

2020 ◽  
Vol 9 (7) ◽  
pp. 2427-2434
Author(s):  
Jiangfeng Wang ◽  
Jurui Luo ◽  
Kairui Jin ◽  
Xuanyi Wang ◽  
Zhaozhi Yang ◽  
...  

2020 ◽  
Vol 16 (1) ◽  
pp. 43-54
Author(s):  
V. V. Semiglazov ◽  
A. A. Natopkin

The article considers the aspects of selection of post-neoadjuvant therapy for patients with residual breast cancer depending on biological subtype and molecular profile of the tumor. Analysis of morphological and molecular markers allowing to evaluate sensitivity of malignant breast tumors with high recurrence risk to new types of systemic treatment is presented.


2015 ◽  
pp. 34
Author(s):  
S. M. DEMIDOV ◽  
S. V. SAZONOV ◽  
D. A. DEMIDOV ◽  
A. Y. SUNTSOVA ◽  
T. O. IRIKH

Sign in / Sign up

Export Citation Format

Share Document